Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
featured
Published in Von Hippel-Lindau Disease

Journal Scan / Research · June 22, 2017

MYC Activation Cooperates With VHL and INK4a/ARF Loss to Induce Clear Cell RCC

Nature Communications

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Dominic Tang MD

Nature Communications
MYC Activation Cooperates With Vhl and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma
Nat Commun 2017 Jun 08;[EPub Ahead of Print], ST Bailey, AM Smith, J Kardos, SE Wobker, HL Wilson, B Krishnan, R Saito, HJ Lee, J Zhang, SC Eaton, LA Williams, U Manocha, DJ Peters, X Pan, TJ Carroll, DW Felsher, V Walter, Q Zhang, JS Parker, JJ Yeh, RA Moffitt, JY Leung, WY Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated